468

Compound name
Pemigatinib
Alt Name
Pemazyre
INCB054828
Compound Image
Pemigatinib.png
SMILES
CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5
MW
487.50
Brutto
C24H27F2N5O4
InChI
InChI=1S/C24H27F2N5O4/c1-4-30-21-14(11-27-23-16(21)9-15(28-23)13-29-5-7-35-8-6-29)12-31(24(30)32)22-19(25)17(33-2)10-18(34-3)20(22)26/h9-11H,4-8,12-13H2,1-3H3,(H,27,28)
InChI Key
HCDMJFOHIXMBOV-UHFFFAOYSA-N
Approval Jurisdiction
2020 FDA
Approved for clinical use
Cholangiocarcinoma With FGFR2 Fusion 
CAS
1513857-77-6
PubChem CID
86705695
Action
FGFR
Approved Drug List
1
Commercial Vendor
Incyte